PFIZER INC Disposal Group, Including Discontinued Operation, Assets
PFIZER INC (PFE) had Disposal Group, Including Discontinued Operation, Assets of $76.00 million as of 2013-12-31, per its 10-K filed 2014-02-28.
Discontinued › Balance Sheet › Assets
us-gaap:AssetsOfDisposalGroupIncludingDiscontinuedOperation · last filed 2014-02-28
- 2013-12-31: Disposal Group, Including Discontinued Operation, Assets $76.00M.
- 2013-09-29: Disposal Group, Including Discontinued Operation, Assets $133.00M.
- 2013-06-30: Disposal Group, Including Discontinued Operation, Assets $100.00M.
- 2012-12-31: Disposal Group, Including Discontinued Operation, Assets $5.94B; Disposal Group, Including Discontinued Operation, Assets as first filed $70.00M.
| Period end | Disposal Group, Including Discontinued Operation, Assets | Disposal Group, Including Discontinued Operation, Assets as first filed |
|---|---|---|
| 2013-12-31 | $76.00M 10-K · filed 2014-02-28 | |
| 2013-09-29 | $133.00M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $100.00M 10-Q · filed 2013-08-09 | |
| 2012-12-31 | $5.94B 10-K · filed 2014-02-28 | $70.00M 10-K · filed 2013-02-28 |
| 2012-09-30 | $5.27B 10-Q · filed 2012-11-09 | |
| 2012-07-01 | $5.36B 10-Q · filed 2012-08-09 | |
| 2012-04-01 | $159.00M 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $5.32B 10-K · filed 2013-02-28 | $101.00M 10-K · filed 2012-02-28 |
| 2011-10-02 | $122.00M 10-Q · filed 2011-11-10 | |
| 2011-07-03 | $1.48B 10-Q · filed 2011-08-11 | |
| 2011-04-03 | $1.43B 10-Q · filed 2011-05-12 | |
| 2010-12-31 | $1.44B 10-K · filed 2012-02-28 | $561.00M 10-K · filed 2011-02-28 |
| 2010-10-03 | $494.00M 10-Q · filed 2010-11-12 | |
| 2010-07-04 | $682.00M 10-Q · filed 2010-08-12 | |
| 2010-04-04 | $490.00M 10-Q · filed 2010-05-13 | |
| 2009-12-31 | $496.00M 10-K · filed 2011-02-28 | |
| 2009-09-27 | $231.00M 10-Q · filed 2009-11-05 | |
| 2009-06-28 | $219.00M 10-Q · filed 2009-08-06 | |
| 2008-12-31 | $148.00M 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |